Moderna boosts unicorn status with a whopping $500M raise and $7B valuation
The biotech world’s biggest unicorn just raised $500 million, bringing its total haul to about $2.5 billion from partnerships and investors while valuing the company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
